Mental Health Services for Prisoners With SMI
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03713398 |
|
Recruitment Status :
Completed
First Posted : October 19, 2018
Results First Posted : September 23, 2021
Last Update Posted : October 27, 2021
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Mental Disorder | Behavioral: T4C-SMI | Not Applicable |
Interventions are urgently needed to improve the delivery and impact of mental health services for persons with serious mental illnesses (SMI) in prison. Treatments addressing the symptoms of mental illness form a critical component of the continuum of services needed by prisoners with SMI. However, a growing body of literature shows that mental health treatments need to be combined with treatments that directly address criminogenic risk factors (i.e., those factors most closely associated with criminal activities). Despite promising evidence, interventions that address criminogenic risk factors, such as Thinking for a Change (T4C), are not used with prisoners with SMI because of the neurocognitive and social impairments associated with SMI. This study examines the effectiveness of T4C with a modified delivery system designed specifically to address the unique needs of persons with SMI in prison. This small-scale randomized controlled trail (RCT) explores the potential effectiveness of T4C-SMI towards improving impulsivity, criminal attitudes, and interpersonal problem solving (treatment targets) and levels of aggression, and the amount of behavioral infractions and time spent in administrative segregation in prison (outcomes). The study will also examine whether the treatment targets for T4C-SMI mediate the intervention's impact on outcomes.
The long-term goal is to grow the evidence-base for interventions with the capacity to improve prison and community-reentry outcomes for persons with SMI. This study will provide the data needed to implement a rigorous RCT in a future study and supports NIMH's mission to develop innovative interventions in mental health services.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 100 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Health Services Research |
| Official Title: | Improving Mental Health Services for Prisoners With Serious Mental Illnesses |
| Actual Study Start Date : | January 3, 2019 |
| Actual Primary Completion Date : | December 6, 2020 |
| Actual Study Completion Date : | December 6, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: T4C-SMI Group
Participants will receive the T4C-SMI intervention, in addition to standard prison mental health services
|
Behavioral: T4C-SMI
T4C-SMI entails a 25-session, manualized intervention that is delivered in a closed-group format at least twice a week over a three-month period. The intervention curriculum includes three modules: nine sessions on social skills training, five sessions on cognitive restructuring activities, and ten sessions on problem-solving methods. Participants assigned to T4C-SMI receive this intervention in addition to any other prison mental health services that they are otherwise eligible to receive during their incarceration. |
|
No Intervention: Control Group
The control group receives standard prison mental health services
|
- Change in Levels of Aggression Score From Baseline to Month 3 [ Time Frame: Baseline, Month 3 ]Aggression Questionnaire - Short Form is a 12-item measure with four subscales: physical aggression, verbal aggression, anger, and hostility. Items are scored on a 6-point Likert scale. Scores range from 12 to 72. The higher the score the more aggression present.
- Change in Levels of Aggression Score From Baseline to Month 6 [ Time Frame: Baseline, Month 6 ]Aggression Questionnaire - Short Form is a 12-item measure with four subscales: physical aggression, verbal aggression, anger, and hostility. Items are scored on a 6-point Likert scale. Scores range from 12 to 72. The higher the score the more aggression present.
- Number of Participants With Post Test Behavioral Infractions [ Time Frame: End of intervention through Month 9, approximately 6 months total ]Number of participants who have at least 1 behavioral infraction following the intervention. Prison records used to ascertain the number of participants who receive behavioral infractions.
- Median Number of Days in Administrative Segregation [ Time Frame: End of intervention through Month 9, approximately 6 months total ]Prison records will be used to determine the total number of days participants are placed in administrative segregation.
- Change in Overall Interpersonal Problem Solving Score [ Time Frame: Baseline, Month 3 ]The Social Problem Solving Inventory - Revised, Long (SPSI-R:L) is a 52-item measure of problem solving skills and problem orientation. Items are measured on a 5-point Likert scale. It has three subscales: problem orientation, problem solving skills, and social problem-solving inventory. The total raw score range is from 0 to 20. Higher score mean more positive social problem solving skills.
- Change in Overall Criminal Attitudes Score [ Time Frame: Baseline, Month 3 ]The Measure of Criminal Attitudes and Associates (MCAA) Part B is a 46-item measure. Responses are recorded in an agree/disagree format. MCAA includes four scales: attitudes toward violence, sentiments of entitlement, antisocial intent, and associates. Scores range from 0 to 46. Lower scores indicate lower levels of criminal attitudes.
- Change in Overall Impulsivity Score [ Time Frame: Baseline, Month 3 ]Barratt Impulsiveness Scale (BIS-11) is a 30 item self-report measure. Items scored on a 4-point Likert scale. It is comprised of six subscales including attention, cognitive instability, perseverance, self-control, motor impulsiveness, and cognitive complexity. The total score ranges from 30 to 120. Lower scores indicate lower levels of impulsiveness.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- aged 18 years or older
- have a diagnosis of schizophrenia, schizoaffective disorder, psychotic disorder, bipolar disorder with psychotic features or major depressive disorder with psychotic features
- have moderate to high risk levels of criminogenic risk factors as determined by the Level of Service and Case Management Inventory (LS/CMI)
- have at least one year or more remaining on their prison sentence at the time of the screening interview
Exclusion Criteria:
- has participated in T4C-SMI within 6 months prior to study
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03713398
| United States, North Carolina | |
| North Carolina Department of Public Safety | |
| Raleigh, North Carolina, United States, 27699 | |
| Principal Investigator: | Amy B Wilson, PhD | UNC Chapel Hill |
Documents provided by University of North Carolina, Chapel Hill:
| Responsible Party: | University of North Carolina, Chapel Hill |
| ClinicalTrials.gov Identifier: | NCT03713398 |
| Other Study ID Numbers: |
16-3154 R34MH111855 ( U.S. NIH Grant/Contract ) |
| First Posted: | October 19, 2018 Key Record Dates |
| Results First Posted: | September 23, 2021 |
| Last Update Posted: | October 27, 2021 |
| Last Verified: | August 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Mental Disorders |

